Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar,Jie Liu,Yun Ji,Murugan Subramanian,Joseph G. Crompton,Zhiya Yu,Rahul Roychoudhuri,Douglas C. Palmer,Pawel Muranski,Edward D. Karoly,Robert P. Mohney,Christopher A. Klebanoff,Ashish Lal,Toren Finkel,Nicholas P. Restifo,Luca Gattinoni +15 more
Reads0
Chats0
TLDR
It is indicated that augmenting glycolytic flux drives CD8+ T cells toward a terminally differentiated state, while its inhibition preserves the formation of long-lived memory CD8+, and the efficacy of T cell-based therapies against chronic infectious diseases and cancer.Abstract:
Naive CD8+ T cells rely upon oxidation of fatty acids as a primary source of energy. After antigen encounter, T cells shift to a glycolytic metabolism to sustain effector function. It is unclear, however, whether changes in glucose metabolism ultimately influence the ability of activated T cells to become long-lived memory cells. We used a fluorescent glucose analog, 2-NBDG, to quantify glucose uptake in activated CD8+ T cells. We found that cells exhibiting limited glucose incorporation had a molecular profile characteristic of memory precursor cells and an increased capacity to enter the memory pool compared with cells taking up high amounts of glucose. Accordingly, enforcing glycolytic metabolism by overexpressing the glycolytic enzyme phosphoglycerate mutase-1 severely impaired the ability of CD8+ T cells to form long-term memory. Conversely, activation of CD8+ T cells in the presence of an inhibitor of glycolysis, 2-deoxyglucose, enhanced the generation of memory cells and antitumor functionality. Our data indicate that augmenting glycolytic flux drives CD8+ T cells toward a terminally differentiated state, while its inhibition preserves the formation of long-lived memory CD8+ T cells. These results have important implications for improving the efficacy of T cell–based therapies against chronic infectious diseases and cancer.read more
Citations
More filters
Posted ContentDOI
CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor
May Daher,Rafet Basar,Elif Gokdemir,Natalia Baran,Nadima Uprety,Ana Karen Nunez Cortes,Mayela Mendt,Lucila Nassif Kerbauy,Lucila Nassif Kerbauy,Pinaki P. Banerjee,Mayra Hernandez Sanabria,Nobuhiko Imahashi,Li Li,Francesca Lorraine Wei Inng Lim,Mohsen Fathi,Ali Rezvan,Vakul Mohanty,Yifei Shen,Hila Shaim,Junjun Lu,Gonca Ozcan,Emily Ensley,Mecit Kaplan,Vandana Nandivada,Mustafa Bdaiwi,Sunil Acharya,Yuanxin Xi,Xinhai Wan,Duncan Mak,Enli Liu,Sonny Ang,Luis Muniz-Feliciano,Ye Li,Jing Wang,Shahram Kordasti,Nedyalko Petrov,Navin Varadarajan,David Marin,Lorenzo Brunetti,Richard Skinner,Shangrong Lyu,Leiser Silva,Rolf Turk,Mollie S. Schubert,Garrett R. Rettig,Matthew S. McNeill,Gavin Kurgan,Mark A. Behlke,Heng Li,Natalie W. Fowlkes,Ken Chen,Marina Konopleva,Richard E. Champlin,Elizabeth J. Shpall,Katayoun Rezvani +54 more
TL;DR: It is concluded that combining CIS checkpoint deletion with CAR engineering promotes the metabolic fitness of NK cells in an otherwise suppressive tumor microenvironment, and represents a promising milestone in the development of the next generation ofNK cells for cancer immunotherapy.
Journal ArticleDOI
Targeting Monocarboxylate Transporters (MCTs) in cancer: How close are we to the clinics?
Mamta Singh,Julieta Afonso,Dolly Sharma,Rajat K. Gupta,V. Kumar,Reshma Rani,Fátima Baltazar,Vinit Kumar +7 more
TL;DR: An overview of the role of MCT isoforms in cancer and summarizes the recent advances in their pharmacological targeting, highlighting the potential of new potent and selective MCT1 and/or MCT4 inhibitors in cancer therapeutics as mentioned in this paper .
Dissertation
Intérêt de l’utilisation de stratégies anti-métaboliques pour le traitement du cancer du sein
TL;DR: In this article, the authors evaluate l'acide lipoique (LA) anti-proliferatif effect on the proliferation of different types of lignees cellulaires du cancer du sein and d'etudier ses mecanismes.
Journal ArticleDOI
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Xiaoxia Chi,Shahang Luo,Pengxu Wei and Derong Ye,Wei Lun Hwang,Jong Ho Cha,Xiuwen Yan,Wen Hao Yang +6 more
TL;DR: In this article , the authors describe the research progress on T-cell exhaustion and stemness in the field of cancer immunotherapy and summarize advances in potential strategies to intervene and treat chronic infection and cancer.
Journal ArticleDOI
Optimizing the manufacturing and antitumour response of CAR T therapy
TL;DR: In this article , the authors provide an overview of specific T cell attributes that influence the performance of adoptive T cell transfers, including memory T cell population, CD4:CD8 composition and CD4 subsets.
References
More filters
Journal ArticleDOI
Lineage relationship and protective immunity of memory CD8 T cell subsets.
E. John Wherry,Volker Teichgräber,Todd C. Becker,David Masopust,Susan M. Kaech,Rustom Antia,Ulrich H. von Andrian,Rafi Ahmed +7 more
TL;DR: It is proposed that TCM and TEM do not necessarily represent distinct subsets, but are part of a continuum in a linear naive → effector → TEM → TCM differentiation pathway.
Journal ArticleDOI
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy
Steven A. Rosenberg,James Chih-Hsin Yang,Richard M. Sherry,Udai S. Kammula,Michael S. Hughes,Giao Q. Phan,Deborah Citrin,Nicholas P. Restifo,Paul F. Robbins,John R. Wunderlich,Kathleen E. Morton,Carolyn M. Laurencot,Seth M. Steinberg,Donald E. White,Mark E. Dudley +14 more
TL;DR: Cell transfer therapy with autologous TILs can mediate durable complete responses in patients with metastatic melanoma and has similar efficacy irrespective of prior treatment.
Journal ArticleDOI
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang,Jonathan D. Curtis,Leonard B. Maggi,Brandon Faubert,Alejandro V. Villarino,David O’Sullivan,Stanley Ching-Cheng Huang,Gerritje J.W. van der Windt,Julianna Blagih,Jing Qiu,Jason D. Weber,Edward J. Pearce,Russell G. Jones,Erika L. Pearce +13 more
TL;DR: It is shown here that aerobic glycolysis is specifically required for effector function in T cells but that this pathway is not necessary for proliferation or survival.
Journal ArticleDOI
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Ruoning Wang,Christopher P. Dillon,Lewis Zhichang Shi,Sandra Milasta,Robert Carter,David Finkelstein,Laura L. McCormick,Patrick Fitzgerald,Hongbo Chi,Joshua Munger,Douglas R. Green +10 more
TL;DR: Metabolic tracer analysis revealed a Myc-dependent metabolic pathway linking glutaminolysis to the biosynthesis of polyamines, which may represent a general mechanism for metabolic reprogramming under patho-physiological conditions.
Journal ArticleDOI
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek,Valerie A. Gerriets,Sarah R. Jacobs,Andrew N. Macintyre,Nancie J. MacIver,Emily F. Mason,Sarah A. Sullivan,Amanda G. Nichols,Jeffrey C. Rathmell +8 more
TL;DR: Teff and Treg were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation.